Why Cancer Drug Prices Keep Rising in the U.S.
It comes as no surprise that cancer drugs cost a lot. Some years ago, researchers even coined the term “financial toxicity” to describe the distress caused by cancer prices. Now, a new study shows that the prices for the top 10 cancer drugs are 42 percent higher in the U.S. than they are in the United Kingdom. No one benefits from this upward spiral except drug companies.